WePharma, Inc., a biopharmaceutical company, develops target…

WePharma, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases. Mara Alarcon, the CEO of the company, insists that employees communicate only through formal channels. Despite these restrictions, she observes many informal networks within the organization. Which one of the following is the most likely reason for establishment of these informal networks?